Kala Market Capitalization from 2010 to 2025
| KALA Stock | USD 6.39 0.18 2.74% |
Check Kala Pharmaceuticals financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Kala Pharmaceuticals' main balance sheet or income statement drivers, such as Interest Expense of 4.9 M, Selling General Administrative of 44 M or Total Revenue of 0.0, as well as many indicators such as Price To Sales Ratio of 16.28, Dividend Yield of 0.0 or PTB Ratio of 2.48. Kala financial statements analysis is a perfect complement when working with Kala Pharmaceuticals Valuation or Volatility modules.
Kala | Market Capitalization |
Latest Kala Pharmaceuticals' Market Capitalization Growth Pattern
Below is the plot of the Market Cap of Kala Pharmaceuticals over the last few years. It is Kala Pharmaceuticals' Market Cap historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Kala Pharmaceuticals' overall financial position and show how it may be relating to other accounts over time.
| View | Last Reported 40.02 M | 10 Years Trend |
|
Market Cap |
| Timeline |
Kala Market Capitalization Regression Statistics
| Arithmetic Mean | 225,982,908 | |
| Geometric Mean | 159,521,800 | |
| Coefficient Of Variation | 77.21 | |
| Mean Deviation | 161,626,080 | |
| Median | 126,233,978 | |
| Standard Deviation | 174,471,839 | |
| Sample Variance | 30440.4T | |
| Range | 389.1M | |
| R-Value | (0.93) | |
| Mean Square Error | 4596.7T | |
| R-Squared | 0.86 | |
| Slope | (33,965,908) | |
| Total Sum of Squares | 456606.3T |
Kala Market Capitalization History
About Kala Pharmaceuticals Financial Statements
Kala Pharmaceuticals stakeholders use historical fundamental indicators, such as Kala Pharmaceuticals' Market Capitalization, to determine how well the company is positioned to perform in the future. Although Kala Pharmaceuticals investors may analyze each financial statement separately, they are all interrelated. For example, changes in Kala Pharmaceuticals' assets and liabilities are reflected in the revenues and expenses on Kala Pharmaceuticals' income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Kala Pharmaceuticals. Please read more on our technical analysis and fundamental analysis pages.
Kala Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of therapies using its proprietary mucus penetrating particles technology for the treatment of eye diseases. Kala Pharmaceuticals, Inc. was incorporated in 2009 and is headquartered in Watertown, Massachusetts. Kala Pharmaceuticals operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on NASDAQ Exchange. It employs 192 people.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.| ZLAB | Zai Lab | |
| ASLE | AerSale Corp | |
| ATS | AT S Austria |
Check out the analysis of Kala Pharmaceuticals Correlation against competitors. For information on how to trade Kala Stock refer to our How to Trade Kala Stock guide.You can also try the Portfolio Manager module to state of the art Portfolio Manager to monitor and improve performance of your invested capital.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Kala Pharmaceuticals. If investors know Kala will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Kala Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Kala Pharmaceuticals is measured differently than its book value, which is the value of Kala that is recorded on the company's balance sheet. Investors also form their own opinion of Kala Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Kala Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Kala Pharmaceuticals' market value can be influenced by many factors that don't directly affect Kala Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Kala Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Kala Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Kala Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.